Cargando…
Targeted Next-Generation Sequencing in a Large Cohort of Genetically Undiagnosed Patients with Neuromuscular Disorders in Spain
The term neuromuscular disorder (NMD) includes many genetic and acquired diseases and differential diagnosis can be challenging. Next-generation sequencing (NGS) is especially useful in this setting given the large number of possible candidate genes, the clinical, pathological, and genetic heterogen...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288461/ https://www.ncbi.nlm.nih.gov/pubmed/32403337 http://dx.doi.org/10.3390/genes11050539 |
_version_ | 1783545281526104064 |
---|---|
author | Gonzalez-Quereda, Lidia Rodriguez, Maria Jose Diaz-Manera, Jordi Alonso-Perez, Jorge Gallardo, Eduard Nascimento, Andres Ortez, Carlos Natera-de Benito, Daniel Olive, Montse Gonzalez-Mera, Laura Lopez de Munain, Adolfo Zulaica, Miren Poza, Juan Jose Jerico, Ivonne Torne, Laura Riera, Pau Milisenda, Jose Sanchez, Aurora Garrabou, Gloria Llano, Isabel Madruga-Garrido, Marcos Gallano, Pia |
author_facet | Gonzalez-Quereda, Lidia Rodriguez, Maria Jose Diaz-Manera, Jordi Alonso-Perez, Jorge Gallardo, Eduard Nascimento, Andres Ortez, Carlos Natera-de Benito, Daniel Olive, Montse Gonzalez-Mera, Laura Lopez de Munain, Adolfo Zulaica, Miren Poza, Juan Jose Jerico, Ivonne Torne, Laura Riera, Pau Milisenda, Jose Sanchez, Aurora Garrabou, Gloria Llano, Isabel Madruga-Garrido, Marcos Gallano, Pia |
author_sort | Gonzalez-Quereda, Lidia |
collection | PubMed |
description | The term neuromuscular disorder (NMD) includes many genetic and acquired diseases and differential diagnosis can be challenging. Next-generation sequencing (NGS) is especially useful in this setting given the large number of possible candidate genes, the clinical, pathological, and genetic heterogeneity, the absence of an established genotype-phenotype correlation, and the exceptionally large size of some causative genes such as TTN, NEB and RYR1. We evaluated the diagnostic value of a custom targeted next-generation sequencing gene panel to study the mutational spectrum of a subset of NMD patients in Spain. In an NMD cohort of 207 patients with congenital myopathies, distal myopathies, congenital and adult-onset muscular dystrophies, and congenital myasthenic syndromes, we detected causative mutations in 102 patients (49.3%), involving 42 NMD-related genes. The most common causative genes, TTN and RYR1, accounted for almost 30% of cases. Thirty-two of the 207 patients (15.4%) carried variants of uncertain significance or had an unidentified second mutation to explain the genetic cause of the disease. In the remaining 73 patients (35.3%), no candidate variant was identified. In combination with patients’ clinical and myopathological data, the custom gene panel designed in our lab proved to be a powerful tool to diagnose patients with myopathies, muscular dystrophies and congenital myasthenic syndromes. Targeted NGS approaches enable a rapid and cost-effective analysis of NMD- related genes, offering reliable results in a short time and relegating invasive techniques to a second tier. |
format | Online Article Text |
id | pubmed-7288461 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72884612020-06-17 Targeted Next-Generation Sequencing in a Large Cohort of Genetically Undiagnosed Patients with Neuromuscular Disorders in Spain Gonzalez-Quereda, Lidia Rodriguez, Maria Jose Diaz-Manera, Jordi Alonso-Perez, Jorge Gallardo, Eduard Nascimento, Andres Ortez, Carlos Natera-de Benito, Daniel Olive, Montse Gonzalez-Mera, Laura Lopez de Munain, Adolfo Zulaica, Miren Poza, Juan Jose Jerico, Ivonne Torne, Laura Riera, Pau Milisenda, Jose Sanchez, Aurora Garrabou, Gloria Llano, Isabel Madruga-Garrido, Marcos Gallano, Pia Genes (Basel) Article The term neuromuscular disorder (NMD) includes many genetic and acquired diseases and differential diagnosis can be challenging. Next-generation sequencing (NGS) is especially useful in this setting given the large number of possible candidate genes, the clinical, pathological, and genetic heterogeneity, the absence of an established genotype-phenotype correlation, and the exceptionally large size of some causative genes such as TTN, NEB and RYR1. We evaluated the diagnostic value of a custom targeted next-generation sequencing gene panel to study the mutational spectrum of a subset of NMD patients in Spain. In an NMD cohort of 207 patients with congenital myopathies, distal myopathies, congenital and adult-onset muscular dystrophies, and congenital myasthenic syndromes, we detected causative mutations in 102 patients (49.3%), involving 42 NMD-related genes. The most common causative genes, TTN and RYR1, accounted for almost 30% of cases. Thirty-two of the 207 patients (15.4%) carried variants of uncertain significance or had an unidentified second mutation to explain the genetic cause of the disease. In the remaining 73 patients (35.3%), no candidate variant was identified. In combination with patients’ clinical and myopathological data, the custom gene panel designed in our lab proved to be a powerful tool to diagnose patients with myopathies, muscular dystrophies and congenital myasthenic syndromes. Targeted NGS approaches enable a rapid and cost-effective analysis of NMD- related genes, offering reliable results in a short time and relegating invasive techniques to a second tier. MDPI 2020-05-11 /pmc/articles/PMC7288461/ /pubmed/32403337 http://dx.doi.org/10.3390/genes11050539 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gonzalez-Quereda, Lidia Rodriguez, Maria Jose Diaz-Manera, Jordi Alonso-Perez, Jorge Gallardo, Eduard Nascimento, Andres Ortez, Carlos Natera-de Benito, Daniel Olive, Montse Gonzalez-Mera, Laura Lopez de Munain, Adolfo Zulaica, Miren Poza, Juan Jose Jerico, Ivonne Torne, Laura Riera, Pau Milisenda, Jose Sanchez, Aurora Garrabou, Gloria Llano, Isabel Madruga-Garrido, Marcos Gallano, Pia Targeted Next-Generation Sequencing in a Large Cohort of Genetically Undiagnosed Patients with Neuromuscular Disorders in Spain |
title | Targeted Next-Generation Sequencing in a Large Cohort of Genetically Undiagnosed Patients with Neuromuscular Disorders in Spain |
title_full | Targeted Next-Generation Sequencing in a Large Cohort of Genetically Undiagnosed Patients with Neuromuscular Disorders in Spain |
title_fullStr | Targeted Next-Generation Sequencing in a Large Cohort of Genetically Undiagnosed Patients with Neuromuscular Disorders in Spain |
title_full_unstemmed | Targeted Next-Generation Sequencing in a Large Cohort of Genetically Undiagnosed Patients with Neuromuscular Disorders in Spain |
title_short | Targeted Next-Generation Sequencing in a Large Cohort of Genetically Undiagnosed Patients with Neuromuscular Disorders in Spain |
title_sort | targeted next-generation sequencing in a large cohort of genetically undiagnosed patients with neuromuscular disorders in spain |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288461/ https://www.ncbi.nlm.nih.gov/pubmed/32403337 http://dx.doi.org/10.3390/genes11050539 |
work_keys_str_mv | AT gonzalezqueredalidia targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT rodriguezmariajose targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT diazmanerajordi targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT alonsoperezjorge targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT gallardoeduard targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT nascimentoandres targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT ortezcarlos targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT nateradebenitodaniel targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT olivemontse targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT gonzalezmeralaura targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT lopezdemunainadolfo targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT zulaicamiren targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT pozajuanjose targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT jericoivonne targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT tornelaura targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT rierapau targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT milisendajose targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT sanchezaurora targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT garrabougloria targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT llanoisabel targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT madrugagarridomarcos targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain AT gallanopia targetednextgenerationsequencinginalargecohortofgeneticallyundiagnosedpatientswithneuromusculardisordersinspain |